Search for: "Novartis Ag"
Results 281 - 300
of 440
Sort by Relevance
|
Sort by Date
24 Feb 2011, 10:39 am
The complaint was brought by Sanford Wittels & Heisler, which has brought similar discrimination suits against drugmaker Novartis AG’s U.S. unit and Toshiba Corp. [read post]
23 Feb 2011, 2:48 pm
Roche’s Boniva had 2010 revenue of $975 million, and Novartis’s Reclast and Aclasta had sales of $579 million.... [read post]
13 Feb 2011, 9:08 pm
Mylan Pharmaceuticals Inc. et al. 1:11-cv-00127; filed February 10, 2011 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
31 Jan 2011, 3:19 am
Coflexip v Stolt (PatLit) Fuzzy boundaries, woolly limitations and over-broad claims: a case-study in insufficiency: Novartis AG & Cibavision AG v Johnson & Johnson (jiplp) ‘Where there is friendship, there is also fun’: President Bauer speaks to the IPKat (IPKat) PCC Page 13: Snails and Octopuses (PatLit) EWHC (Ch) – Galileo and the case of the ventilating hearing officer: Galileo International Technology LLC v European Union (formerly European… [read post]
11 Jan 2011, 11:07 pm
General Steve Burrill makes predictions for the biotech industry in 25th annual report (Patent Docs) Australia: ‘Innovation’ patents in Australia – AMI innovation patent and US investment (IPBiz) Australia: Extension of patent term for pharmaceuticals in Australia: AAT decision in LTS Lohmann Therapie Systeme AG and Schwarz Pharma Ltd and Commissioner of Patents (Patent Baristas) US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O)… [read post]
27 Dec 2010, 6:25 am
In May, a federal jury awarded a class of 5,600 Novartis female sales reps and entry-level managers $250 million to remedy systemic discrimination against women of child-bearing age. [read post]
22 Dec 2010, 3:01 am
Pfizer Health AB & Anor v Schwarz Pharma AG & Ors (PatLit) US: Briefing updates – AMP v. [read post]
2 Dec 2010, 9:28 am
Momenta partnered with Novartis AG’s Sandoz began selling a generic version of the Sanofi-Aventis SA drug Lovenox in July.But note that Teva and Amphastar filed their ANDA applications with the FDA two years before the Momenta-Sandoz partnership filed. [read post]
17 Nov 2010, 1:48 am
(Patent Baristas) A round up of international events – Access and Benefit Sharing Protocol; review of Para 6 system; concerns with ACTA’s compatibility with TRIPS(Spicy IP) Compromise UN protocol treaty against biopiracy adopted in Japan (IP Watch) (Innovation Law Blog) TRIPS Council discusses efficacy of ACTA, public health amendment (IP Watch) Altering genes in crops (IP Osgoode) Asia Pacific Pharmas moving away from generics (GenericsWeb) Belgium Commercial Court: No faultless… [read post]
13 Nov 2010, 9:42 am
Both Advertising Age and Adweek have honored the $2.7 billion agency as “Agency of the Year. [read post]
3 Nov 2010, 7:00 am
Two years later, Momenta Pharmaceuticals Inc. and its partner Sandoz, part of Novartis AG, filed. [read post]
18 Oct 2010, 3:07 am
SEB S.A (Patently-O) (Inventive Step) (Filewrapper) New false marking bill introduced in the House (Patent Docs) (271 Patent Blog) (FDA Law Blog) UK: Court of Appeal gives guidance on enablement: Novartis AG & Cibavision AG v. [read post]
18 Oct 2010, 1:47 am
An estimated 95% of cases occur in Asia and Africa and up to 60% of cases are in children under 15 years of age. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
5 Oct 2010, 1:56 am
High Court (Queen’s Bench Division) Gray v Crown Prosecution Service [2010] EWHC 2144 (QB) (20 August 2010) High Court (Chancery Division) British Broadcasting Corporation v Harpercollins Publishers Ltd & Anor [2010] EWHC 2424 (Ch) (04 October 2010) High Court (Administrative Court) Hulme, R (on the application of) v Secretary of State for Communities & Local Government [2010] EWHC 2386 (Admin) (19 August 2010) Crown Prosecution Service, R (on the application of) v Kumbaro [2010]… [read post]
4 Oct 2010, 4:35 pm
According to US prosecutors, Novartis Pharmaceuticals Corporation, which is the American subsidiary of Novartis AG of Switzerland, will have to pay criminal fines and forfeitures of $185 million, and more than $237 million to settle civil liabilities arising from its off label marketing. [read post]
1 Oct 2010, 6:08 am
On Thursday, the Justice Department announced it had reached a $422.5 million agreement with the U.S. subsidiary of Novartis AG to resolve criminal and civil charges that it illegally marketed the epilepsy drug Trileptal and paid kickbacks to doctors. [read post]
1 Oct 2010, 4:06 am
The Court of Appeal roared back into action yesterday with its first patent decision of the new term: Novartis AG & Cibavision AG v. [read post]
1 Oct 2010, 3:38 am
Court of Appeal (Civil Division) Novartis AG & Anor v Johnson & Johnson Medical Ltd & Anor [2010] EWCA Civ 1039 (29 September 2010) High Court (Administrative Court) MXL, R (on the application of) & Ors v Secretary of State for the Home Department [2010] EWHC 2397 (Admin) (30 September 2010) High Court (Chancery Division) Anfield (UK) Ltd v Bank of Scotland Plc & Ors [2010] EWHC 2374 (Ch) (24 September 2010) Shepherd v Williamson & Anor [2010] EWHC 2375… [read post]
30 Sep 2010, 5:56 am
Counsel, Sept. 2010 at 28, offers a stunning metric about the number of invoices Novartis AG’s legal and intellectual property groups cope with annually. [read post]
